Drug Delivery Business

Glucotrack to submit continuous blood glucose monitor for FDA IDE in early Q2

Glucotrack (Nasdaq:GCTK) today provided an update on the planned regulatory timeline for its continuous blood glucose monitor ...

Acumen Pharmaceuticals Q4 Earnings Call Highlights

Acumen Pharmaceuticals (NASDAQ:ABOS) outlined progress across its lead Alzheimer’s disease program and an emerging “enhanced ...

A Chinese Medical Device Maker Introduces Real-Time Glucose Monitoring Solution for Chronic Disease Management

Chronic disease management stands at an inflection point. Globally, the number of people living with diabetes continues to climb, and healthcare systems in both developed and emerging markets are ...
TMCnet

Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

Europe's first £1.33-a-day anti-cellulite pill makes 'real difference' to skin folds

I've only been taking it for a couple of months but already starting to see a difference in the appearance of my skin' ...
Investing

Skye Q4 2025 slides: nimacimab combination shows 3% added weight loss

This enzyme-based delivery system degrades hyaluronan to create temporary space for subcutaneous fluid dispersion, enabling injection volumes up to 10-12 mL while potentially improving absorption and ...

Arrowhead Pharmaceuticals Teases Q3 Data Wave: SHASTA-3/4, RNAi Dimer and ARO-MAPT Readouts Ahead

Arrowhead Pharmaceuticals (NASDAQ:ARWR) outlined a slate of expected clinical data updates during a discussion at the Leerink ...
ascopubs.org

Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Clinical Insights ASCO Standards are evidence-based standards to provide frameworks for best practices in cancer ...